Amneal Pharmaceuticals (AMRX) Other Working Capital Changes (2017 - 2026)
Amneal Pharmaceuticals (AMRX) posted quarterly Other Working Capital Changes of $13.4 million for Q1 2026, up 2512.09% year-over-year from $513000.0 in Q1 2025, and up 1426.73% quarter-over-quarter from -$1.0 million in Q4 2025.
Amneal Pharmaceuticals (AMRX) Other Working Capital Changes (2017 - 2026) Analysis & Trends
Amneal Pharmaceuticals' Other Working Capital Changes history runs 10 years deep, the most recent figure standing at $13.4 million for Q1 2026.
- In Q1 2026, Other Working Capital Changes rose 2512.09% year-over-year to $13.4 million; the TTM figure through Mar 2026 stood at $32.0 million (up 413.11% YoY), while the FY2025 annual figure was $19.2 million, up 1898.23% from the prior year.
- Other Working Capital Changes for Q1 2026 stood at $13.4 million, up from -$1.0 million in the prior quarter.
- The five-year high for Other Working Capital Changes was $115.3 million in Q2 2022, with the low at -$85.4 million in Q3 2022.
- The 5-year median for Other Working Capital Changes is -$1.0 million (2025), against an average of -$833764.7.
- The sharpest annual moves came in 2022 and 2026: Other Working Capital Changes tumbled 2535.58% in 2022, then soared 2512.09% in 2026.
- Amneal Pharmaceuticals' Other Working Capital Changes stood at -$44.3 million in 2022, then soared by 70.62% to -$13.0 million in 2023, then soared by 91.36% to -$1.1 million in 2024, then rose by 10.06% to -$1.0 million in 2025, then surged by 1426.73% to $13.4 million in 2026.
- Business Quant data shows AMRX's Other Working Capital Changes at $13.4 million in Q1 2026, -$1.0 million in Q4 2025, and $10.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Haleon | 44.51 Bn | 43.55 Bn | - |
| 2 | Teva Pharmaceutical Industries | 43.52 Bn | 39.86 Bn | 2.15 Bn |
| 3 | Zoetis | 32.43 Bn | 30.75 Bn | 1.05 Bn |
| 4 | Takeda Pharmaceutical | 28.63 Bn | 22.83 Bn | 5.10 Bn |
| 5 | United Therapeutics | 21.87 Bn | 19.21 Bn | 683.80 Mn |
| 6 | Viatris | 18.98 Bn | 18.09 Bn | 1.46 Bn |
| 7 | Neurocrine Biosciences | 15.43 Bn | 15.04 Bn | 935.80 Mn |
| 8 | Elanco Animal Health | 12.02 Bn | 11.49 Bn | 798.00 Mn |
| 9 | Dr Reddys Laboratories | 10.14 Bn | 9.98 Bn | - |
| 10 | Amneal Pharmaceuticals | 5.72 Bn | 5.59 Bn | 334.51 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 10.75 Mn |
| Jun 30, 2026 | 10.75 Mn |
| Jun 30, 2026 | 10.75 Mn |
| Mar 31, 2026 | 13.40 Mn |
| Mar 31, 2026 | 13.40 Mn |
| Mar 31, 2026 | 13.40 Mn |
| Dec 31, 2025 | -1.01 Mn |
| Dec 31, 2025 | -1.01 Mn |
| Dec 31, 2025 | -1.01 Mn |
| Sep 30, 2025 | 10.16 Mn |
| Sep 30, 2025 | 10.16 Mn |
| Sep 30, 2025 | 10.16 Mn |
| Jun 30, 2025 | 9.50 Mn |
| Jun 30, 2025 | 9.50 Mn |
| Jun 30, 2025 | 9.50 Mn |
| Mar 31, 2025 | 513,000.00 |
| Mar 31, 2025 | 513,000.00 |
| Mar 31, 2025 | 513,000.00 |
| Dec 31, 2024 | -1.12 Mn |
| Dec 31, 2024 | -1.12 Mn |